Cvergenx is led by an experienced team of highly trained clinicians, biostatisticians and business professionals with a deep understanding of radiation oncology, genomics, bioinformatics and technology commercialization.
Raymond F. Vennare
Raymond F. Vennare (Chairman & CEO) is an accomplished senior executive and biotechnology entrepreneur with a long history of founding, launching and leading companies ranging bioinformatics, diagnostics and therapeutic drug delivery to FDA-cleared medical devices. In addition to advising nationally ranked universities, philanthropic organizations and multi-national publicly traded companies, Raymond is past co-founder and CEO of Thermal Therapeutic Systems, President and Chief Executive Officer of ImmunoSite, Senior Vice President and Chief Information Officer of TissueInformatics and President of VSinteractive.
Dr. Javier F. Torres-Roca
Dr. Javier F. Torres-Rca (Co-founder & Chief Medical Advisor) is Director of Clinical Research in the Department of Radiation Oncology at Moffitt Cancer Center and clinical faculty with a sub-specialty in urological and cutaneous malignancies. Javier earned his medical degree from the University of Puerto Rico followed by post-doctoral training in immunology and molecular biology with Nobel Laureate Professor Luc Montagnier (Institute Pasteur) and Drs. Irving Weismann and Leonard Herzenberg (Stanford). He completed his clinical training in radiation oncology at the University of California and is an ABR board certified radiation oncologist.
Dr. Steven A. Eschrich
Dr. Steven A. Eschrich (Co-founder & CSO) is Senior Member at the H. Lee Moffitt Cancer Center and Research Institute in the Department of Biostatistics and Bioinformatics, Scientific Director of the Moffitt Cancer Center Cancer Informatics Core Facility and Associate Professor of Oncologic Sciences at the University of South Florida. Dr. Eschrich received his Ph.D. from the University of South Florida with an emphasis on developing scalable machine learning algorithms for bioinformatics applications including extensive experience in gene expression microarray analysis in translational cancer research.
John G. Kokales, MD
John G. Kokales, MD, (Board Director) is a former practicing physician, Senior Medical Director for Medicare and Medical Director for UPMC Health Plan. John chaired the Pharmacy & Therapeutics Committee, co-chaired the Quality Committee for the CMI physician network and chaired the Clinical Pathways Committee at Shadyside Hospital. He is past Member of the Physicians Advisory Committee of the CMI, the Critical Clinical Information Task Force for Cerner Electronic medical record implementation, the Physician Advisory Committee Cerner Hospital implementation and Institutional Review Board at UPMC Shadyside.
Pamela A. Bush, PhD/MBA
Pamela A. Bush, PhD/MBA (Board Director) is the former Director of Corporate Business Development at Eli Lilly & Company where she was lead negotiator for term sheets and contracts to in-license and out-license strategic assets. Before becoming Director or Corporate Business Development, Pamela served as manager in R&D Finance at Lilly and served as Director of Investment Programs for the Pittsburgh Life Sciences Greenhouse in Pittsburgh, PA. Pamela holds a PhD from Carnegie Mellon University, College of Science, and MBA from the Carnegie Mellon University, Tepper School of Business.